These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15363482)

  • 41. Schizophrenia and the immediacy mechanism.
    Salzinger K
    Am Psychol; 2006 Jan; 61(1):74-5. PubMed ID: 16435981
    [No Abstract]   [Full Text] [Related]  

  • 42. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
    Goldberg TE; Goldman RS; Burdick KE; Malhotra AK; Lencz T; Patel RC; Woerner MG; Schooler NR; Kane JM; Robinson DG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1115-22. PubMed ID: 17909123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Symptoms of schizophrenia and neurocognitive test performance.
    Shean G; Burnett T; Eckman FS
    J Clin Psychol; 2002 Jul; 58(7):723-31. PubMed ID: 12205713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Worsening of psychotic symptoms in schizophrenia with addition of lamotrigine: a case report.
    Chan YC; Miller KM; Shaheen N; Votolato NA; Hankins MB
    Schizophr Res; 2005 Oct; 78(2-3):343-5. PubMed ID: 16085390
    [No Abstract]   [Full Text] [Related]  

  • 45. Cognitive effects of conventional and atypical antipsychotics in schizophrenia.
    Sharma T
    Br J Psychiatry Suppl; 1999; (38):44-51. PubMed ID: 10884899
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder.
    Harvey PD; Napolitano JA; Mao L; Gharabawi G
    Int J Geriatr Psychiatry; 2003 Sep; 18(9):820-9. PubMed ID: 12949850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does cognitive function improve with quetiapine in comparison to haloperidol?
    Velligan DI; Newcomer J; Pultz J; Csernansky J; Hoff AL; Mahurin R; Miller AL
    Schizophr Res; 2002 Jan; 53(3):239-48. PubMed ID: 11738537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropsychological impairments in patients with schizophrenia: stability and prediction of outcome.
    Gråwe RW; Levander S
    Acta Psychiatr Scand Suppl; 2001; (408):60-4. PubMed ID: 11730074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Could repetitive transcranial magnetic stimulation improve neurocognition in early-onset schizophrenia spectrum disorders?
    Croarkin PE; Daskalakis ZJ
    J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):949-51. PubMed ID: 22917209
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of severely psychotic inpatients with schizophrenia: olanzapine versus other antipsychotic drugs.
    Carrasco JL; Gutiérrez M; Gómez JC; Escobar R; Alvarez E; Cañas F; Bobes J; Gascón J; Gibert J
    Int Clin Psychopharmacol; 2002 Nov; 17(6):287-95. PubMed ID: 12409682
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia.
    Molina V; Gispert JD; Reig S; Pascau J; Martínez R; Sanz J; Palomo T; Desco M
    Int Clin Psychopharmacol; 2005 Jan; 20(1):13-8. PubMed ID: 15602110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of the selective norepinephrine reuptake inhibitor reboxetine on cognitive dysfunction in schizophrenia patients: an add-on, double-blind placebo-controlled study.
    Poyurovsky M; Faragian S; Fuchs C; Pashinian A
    Isr J Psychiatry Relat Sci; 2009; 46(3):213-20. PubMed ID: 20039523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia.
    Sharma T; Hughes C; Soni W; Kumari V
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):398-403. PubMed ID: 12845415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective study.
    Hori H; Ueda N; Yoshimura R; Yamamoto H; Wani K; Etoh Y; Haraga K; Kitahara J; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 3):741-5. PubMed ID: 19707954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone.
    Tollefson GD; Andersen SW; Tran PV
    Biol Psychiatry; 1999 Aug; 46(3):365-73. PubMed ID: 10435202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients.
    Fujii DE; Ahmed I; Jokumsen M; Compton JM
    J Neuropsychiatry Clin Neurosci; 1997; 9(2):240-5. PubMed ID: 9144103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between subjective cognitive symptoms and frontal executive abilities in chronic schizophrenic outpatients.
    Zanello A; Huguelet P
    Psychopathology; 2001; 34(3):153-8. PubMed ID: 11316962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone.
    Riedel M; Schennach-Wolff R; Musil R; Dehning S; Cerovecki A; Opgen-Rhein M; Matz J; Seemüller F; Obermeier M; Engel RR; Müller N; Möller HJ; Spellmann I
    Hum Psychopharmacol; 2010 Mar; 25(2):116-25. PubMed ID: 20196179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.
    Rémillard S; Pourcher E; Cohen H
    Schizophr Res; 2005 Dec; 80(1):99-106. PubMed ID: 16162401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.
    Roiz-Santiáñez R; Tordesillas-Gutiérrez D; Ortíz-García de la Foz V; Ayesa-Arriola R; Gutiérrez A; Tabarés-Seisdedos R; Vázquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2012 Oct; 141(1):22-8. PubMed ID: 22884754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.